Increasing adverse drug reaction reporting—How can we do better?

por Potlog Shchory, Miri, Goldstein, Lee H., Arcavi, Lidia, Shihmanter, Renata, Berkovitch, Matitiahu, Levy, Amalia
Publicado 2020

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA

por Hiayev, Stephany, Shacham-Shmueli, Einat, Berkovitch, Matitiahu, Weiss, Ilana, Ashkenazi, Shai, Vexberg, Michal Hirsch, Hershkowitz, Rami, Gorelik, Einat, Mayan, Haim, Steinmetz, Yehudit, Yanai, Noa Berar, Schlissel, Orly, Azem, Muhammad, Gutgold, Neriya, Shulman, Katerina, Divinsky, Milly, Yarom, Nirit, Vishkautzan, Alla, Ganzel, Chezi, Gatt, Moshe E, Arcavi, Lidia, Marom, Eli, Uziely, Biatrice, Zevin, Shoshana, Meirow, Hadar, Luxenburg, Osnat, Ainbinder, Denize
Publicado 2023